Zdrowie i gospodarka · 20/09/2019
FDA Seeks Public Input on Abuse-Deterrent Formulations of Prescription Stimulants
The Food and Drug Administration is soliciting comments from various stakeholders on the potential role of abuse-deterrent formulations of central nervous system stimulants in addressing public health concerns related to prescription stimulant misuse and abuse.